Pharmaceutical policies: effects on rational drug use
暂无分享,去创建一个
C. Furberg | S. Hill | A. Oxman | C. Ramsay | S. Soumerai | D. Ross-Degnan | A. Austvoll-Dahlgren | R. Grilli | M. Aaserud | J. P. Kösters | D. Henry | H. Sturm
[1] S. Michie,et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. , 2017, The Cochrane database of systematic reviews.
[2] A. Oxman,et al. Pharmaceutical policies: effects of financial incentives for prescribers. , 2007, The Cochrane database of systematic reviews.
[3] A. Oxman,et al. Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies. , 2014, The Cochrane database of systematic reviews.
[4] J. McNeil,et al. Reference-Based Pricing Schemes , 2012, PharmacoEconomics.
[5] A. Oxman,et al. Pharmaceutical policies: effects of cap and co-payment on rational drug use. , 2008, The Cochrane database of systematic reviews.
[6] G. Guyatt,et al. Grading quality of evidence and strength of recommendations , 2004, BMJ : British Medical Journal.
[7] Craig R Ramsay,et al. INTERRUPTED TIME SERIES DESIGNS IN HEALTH TECHNOLOGY ASSESSMENT: LESSONS FROM TWO SYSTEMATIC REVIEWS OF BEHAVIOR CHANGE STRATEGIES , 2003, International Journal of Technology Assessment in Health Care.
[8] C. Ramsay,et al. Mass media interventions: effects on health services utilisation. , 2002, The Cochrane database of systematic reviews.
[9] S. Soumerai,et al. Do national medicinal drug policies and essential drug programs improve drug use?: a review of experiences in developing countries. , 2001, Social science & medicine.
[10] F. Haaijer-Ruskamp,et al. Intervention research in rational use of drugs: a review. , 1999, Health policy and planning.
[11] N. Freemantle,et al. Lessons from international experience in controlling pharmaceutical expenditure III: regulating industry , 1996, BMJ.
[12] N. Freemantle,et al. Fortnightly Review: Lessons from international experience in controlling pharmaceutical expenditure II: influencing doctors , 1996, BMJ.
[13] N. Freemantle,et al. Lessons from international experience in controlling pharmaceutical expenditure. I: influencing patients , 1996, BMJ.
[14] S. Soumerai,et al. A critical analysis of studies of state drug reimbursement policies: research in need of discipline. , 1993, The Milbank quarterly.
[15] S B Soumerai,et al. Effects of Medicaid drug-payment limits on admission to hospitals and nursing homes. , 1991, The New England journal of medicine.
[16] Stephen B. Soumerai,et al. Payment Restrictions for Prescription Drugs under Medicaid , 1987 .